Pfizer's personalized medicine revenues exceed $5B by 2027

Pfizer will launch a portfolio of personalized medicine drugs targeting rare diseases by 2026. These drugs will generate over $5 billion in annual revenue by the end of 2027, driven by FDA approvals and commercial partnerships.

Implied probability (Yes)

60%